Evidence map›Paper›PMID 41365966›Full record

ArticleScientific reports2025

Estimated glucose disposal rate and frailty in middle and older aged adults from three prospective cohorts.

Yan Li, Xi Ye, Xiaoyu Chen, Xueyan Liang

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yan Li *Department of Clinical Pharmacy, Guangxi Academy of Medical Sciences, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People's Republic of China.
Xi Ye *Department of Clinical Pharmacy, Guangxi Academy of Medical Sciences, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People's Republic of China.
Xiaoyu ChenDepartment of Clinical Pharmacy, Guangxi Academy of Medical Sciences, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People's Republic of China.
Xueyan LiangPhase I Clinical Trial Laboratory, Guangxi Academy of Medical Sciences, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People's Republic of China. liangxueyan20102010@outlook.com.

Funding

Drug Safety Research Project of Guangxi Zhuang Autonomous Region Guiyaojiankezhishu[2023]017
6 · The paper itself

Abstract

Insulin resistance (IR) has been associated with incident frailty. However, the precise association between the estimated glucose disposal rate (eGDR) and the development of frailty remains insufficiently understood. We hypothesized that a lower eGDR, indicating greater IR, would be associated with a higher risk of developing frailty and with accelerated frailty progression across cohorts. This study aimed to systematically investigate and clarify this association. Data were obtained from three prospective cohorts: the China Health and Retirement Longitudinal Study (CHARLS), the English Longitudinal Study of Ageing (ELSA), and the Health and Retirement Study (HRS). Frailty was assessed using the Rockwood Frailty Scale. Baseline eGDR, changes in eGDR, and cumulative eGDR from baseline to the most recent survey wave, as well as the frailty index for each survey year, were evaluated. Logistic and Cox regression models were used to examine the association between eGDR and incident frailty. To assess frailty progression over time, we applied linear mixed-effects models and evaluated potential nonlinear trends. In addition, K-means clustering was conducted as an exploratory analysis to describe heterogeneity in longitudinal eGDR trajectories. A total of 7,666 participants were included from CHARLS (female: 51%, mean age: 58.27 years), 4,296 from ELSA (female: 53%, mean age: 64.89 years), and 4,370 from HRS (female: 56%, mean age: 66.63 years). A significant association was observed between lower eGDR and an increased risk of frailty (hazard ratio [HR]: 0.91, 95% CI 0.88-0.94; HR: 0.90, 95% CI 0.87-0.94; and HR: 0.95, 95% CI 0.92-0.98 for CHARLS, ELSA, and HRS, respectively) and with an accelerated increase in frailty index (β: -0.005, 95% CI -0.007 to - 0.004; β: -0.009, 95% CI -0.010 to - 0.008; and β: -0.009, 95% CI -0.010 to - 0.008 for CHARLS, ELSA, and HRS, respectively). Similarly, increases in cumulative eGDR and in changes in eGDR over time were associated with lower risks of incident frailty and frailty index. Subgroup and sensitivity analyses demonstrated consistent findings across subgroups. The elbow method suggested that three clusters represented the optimal solution; however, these clusters did not differ significantly in frailty outcomes and were therefore interpreted as descriptive rather than predictive. These findings highlight the importance of early detection of eGDR reduction and the implementation of targeted interventions to mitigate incident frailty.

Indexed as

Blood GlucoseFrailtyGlucoseInsulin ResistanceAgedAgingChinaFemaleFrail ElderlyHumansLongitudinal StudiesMaleMiddle AgedProspective StudiesRisk FactorsBlood GlucoseGlucoseEpidemiologyEstimated glucose disposal rateFrailtyInsulin resistanceLongitudinal study

Identifiers

PMID41365966
PMCPMC12764994

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.